Dabigatran approved for VTE prevention and treatment

The novel oral anticoagulant dabigatran has been approved for treating and reducing the risk of recurrence of deep venous thrombosis and pulmonary embolism, based on the results of four phase III...

Field of Interest: Cardiology
Type: News Item

VIDEO: Rethink the VTE prophylaxis mantra

LAS VEGAS – Venous thromboembolism prophylaxis – a sine qua non of the Joint Commission and others – doesn’t seem to prevent deep vein thrombosis or pulmonary embolism in hospitalized medical...

Field of Interest: Cardiology
Type: News Item

Tuberculosis rate drops, disparity continues

Despite the overall decline in tuberculosis, there continues to be a large disparity in incidence between U.S.-born and foreign-born U.S. residents, the Centers for Disease Control and Prevention...

Field of Interest: Infectious diseases
Type: News Item

Two definitions of Gulf War illness recommended

An Institute of Medicine committee could not reach consensus on a single definition of Gulf War illness and recommended in a new report that clinicians and researchers at least narrow it down to two...

Field of Interest: Gastroentero...
Type: News Item

Two definitions of Gulf War illness recommended

An Institute of Medicine committee could not reach consensus on a single definition of Gulf War illness and recommended in a new report that clinicians and researchers at least narrow it down to two...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.